Skip to main content
. 2020 Oct 28;9(11):3479. doi: 10.3390/jcm9113479

Figure 2.

Figure 2

Early conversion to belatacept as a risk factor for an opportunistic infection (OPI). Kaplan–Meier analysis curve of OPI-free survival in kidney transplant recipients converted earlier (<6-months) and later (≥6-months) to belatacept (A) and of recipients converted to belatacept before <8-months and after ≥8-months (B).